Scientists test aggressive combo to shrink tumors before surgery
NCT ID NCT07182565
Summary
This study is testing a new pre-surgery treatment for a type of cancer where the stomach meets the esophagus. Researchers want to see if adding a special, shorter course of radiation to standard immunotherapy and chemotherapy is safe and can help shrink tumors more effectively before an operation. The goal is to improve the chance that surgery removes all the cancer and to see if this approach helps patients live longer without the disease returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Seventh People's Hospital of Chengdu
RECRUITINGChengdu, Sichuan, 610041, China
-
West China Hospital, Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
-
West China Shangjin Nanfu Hospital, Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
-
West China Xiamen Hospital, Sichuan University
RECRUITINGXiamen, Fujian, China
Conditions
Explore the condition pages connected to this study.